RU2010133049A - MEDICINAL PRODUCT AND METHOD FOR PREVENTION OF HIV INFECTION, PREVENTION AND TREATMENT OF DISEASES CAUSED BY HIV OR ASSOCIATED WITH HIV, INCLUDING AIDS - Google Patents
MEDICINAL PRODUCT AND METHOD FOR PREVENTION OF HIV INFECTION, PREVENTION AND TREATMENT OF DISEASES CAUSED BY HIV OR ASSOCIATED WITH HIV, INCLUDING AIDS Download PDFInfo
- Publication number
- RU2010133049A RU2010133049A RU2010133049/15A RU2010133049A RU2010133049A RU 2010133049 A RU2010133049 A RU 2010133049A RU 2010133049/15 A RU2010133049/15 A RU 2010133049/15A RU 2010133049 A RU2010133049 A RU 2010133049A RU 2010133049 A RU2010133049 A RU 2010133049A
- Authority
- RU
- Russia
- Prior art keywords
- aqueous
- antibodies
- hiv
- solution
- activated potentiated
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract 8
- 230000002265 prevention Effects 0.000 title claims abstract 8
- 238000011282 treatment Methods 0.000 title claims abstract 5
- 208000030507 AIDS Diseases 0.000 title claims abstract 4
- 208000031886 HIV Infections Diseases 0.000 title claims abstract 4
- 208000037357 HIV infectious disease Diseases 0.000 title claims abstract 4
- 201000010099 disease Diseases 0.000 title claims abstract 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title claims abstract 4
- 208000033519 human immunodeficiency virus infectious disease Diseases 0.000 title claims abstract 4
- 229940126601 medicinal product Drugs 0.000 title 1
- 239000000243 solution Substances 0.000 claims abstract 18
- 239000003814 drug Substances 0.000 claims abstract 12
- 229940079593 drug Drugs 0.000 claims abstract 12
- 238000010790 dilution Methods 0.000 claims abstract 11
- 239000012895 dilution Substances 0.000 claims abstract 11
- 108010041397 CD4 Antigens Proteins 0.000 claims abstract 9
- 239000011159 matrix material Substances 0.000 claims abstract 9
- 239000000654 additive Substances 0.000 claims abstract 3
- 230000000694 effects Effects 0.000 claims abstract 3
- 239000002904 solvent Substances 0.000 claims abstract 3
- 230000007935 neutral effect Effects 0.000 claims abstract 2
- 229920006395 saturated elastomer Polymers 0.000 claims abstract 2
- 239000007909 solid dosage form Substances 0.000 claims abstract 2
- 230000001632 homeopathic effect Effects 0.000 claims 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims 1
- 238000007865 diluting Methods 0.000 claims 1
- 238000011037 discontinuous sequential dilution Methods 0.000 claims 1
- 239000008101 lactose Substances 0.000 claims 1
- 235000019359 magnesium stearate Nutrition 0.000 claims 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims 1
- 239000008108 microcrystalline cellulose Substances 0.000 claims 1
- 229940016286 microcrystalline cellulose Drugs 0.000 claims 1
- 239000011550 stock solution Substances 0.000 claims 1
- 238000013207 serial dilution Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0004—Homeopathy; Vitalisation; Resonance; Dynamisation, e.g. esoteric applications; Oxygenation of blood
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
- C07K16/2812—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against CD4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Genetics & Genomics (AREA)
- Hematology (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- AIDS & HIV (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Communicable Diseases (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
1. Лекарственное средство для профилактики инфицирования ВИЧ, профилактики и лечения заболеваний, вызываемых ВИЧ или ассоциированных с ВИЧ, в том числе СПИДа, характеризующееся тем, что содержит активированную потенцированную форму антител к CD4 рецептору. ! 2. Лекарственное средство по п.1, характеризующееся тем, что активированную потенцированную форму антител к CD4 рецептору используют в виде активированного потенцированного водного или водно-спиртового раствора, активность которого обусловлена процессом последовательного многократного разведения матричного исходного раствора антител в водном или водно-спиртовом растворителе в сочетании с внешним механическим воздействием - вертикальным встряхиванием каждого разведения. ! 3. Лекарственное средство по п.1 или 2, характеризующееся тем, что выполнено в твердой лекарственной форме и содержит технологически необходимое количество нейтрального носителя, насыщенного водным или водно-спиртовым раствором активированной потенцированной формы антител к CD4 рецептору, и фармацевтически приемлемые добавки. ! 4. Лекарственное средство по п.1 или 2, характеризующееся тем, что водный или водно-спиртовой раствор активированной потенцированной формы антител к CD4 рецептору получен путем многократного последовательного разведения матричного - исходного - раствора антител в сочетании с внешним механическим воздействием - вертикальным встряхиванием каждого разведения, при этом концентрация матричного раствора составляет 0,5÷5,0 мг/мл. ! 5. Лекарственное средство по п.1 или 2, характеризующееся тем, что водный или водно-спиртовой раствор активированной потенцированной фор� 1. A drug for the prevention of HIV infection, the prevention and treatment of diseases caused by HIV or associated with HIV, including AIDS, characterized in that it contains an activated potentiated form of antibodies to the CD4 receptor. ! 2. The drug according to claim 1, characterized in that the activated potentiated form of antibodies to the CD4 receptor is used in the form of an activated potentiated aqueous or aqueous-alcoholic solution, the activity of which is due to the process of sequential multiple dilution of the matrix initial solution of antibodies in an aqueous or aqueous-alcoholic solvent in combination with external mechanical action - vertical shaking of each dilution. ! 3. The drug according to claim 1 or 2, characterized in that it is in solid dosage form and contains the technologically necessary amount of a neutral carrier saturated with an aqueous or aqueous-alcoholic solution of an activated potentiated form of antibodies to the CD4 receptor, and pharmaceutically acceptable additives. ! 4. The drug according to claim 1 or 2, characterized in that the aqueous or aqueous-alcoholic solution of the activated potentiated form of antibodies to the CD4 receptor is obtained by repeated serial dilution of the matrix - initial - antibody solution in combination with an external mechanical action - vertical shaking of each dilution while the concentration of the matrix solution is 0.5 ÷ 5.0 mg / ml ! 5. The drug according to claim 1 or 2, characterized in that the aqueous or aqueous-alcoholic solution of the activated potentiated form
Claims (10)
Priority Applications (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2010133049/15A RU2010133049A (en) | 2010-08-06 | 2010-08-06 | MEDICINAL PRODUCT AND METHOD FOR PREVENTION OF HIV INFECTION, PREVENTION AND TREATMENT OF DISEASES CAUSED BY HIV OR ASSOCIATED WITH HIV, INCLUDING AIDS |
| FR1156471A FR2963562A1 (en) | 2010-08-06 | 2011-07-15 | PHARMACEUTICAL COMPOSITION AND USE THEREOF IN A PROCESS FOR INHIBITING PRODUCTION OF OR AMPLIFYING THE ELIMINATION OF P24 PROTEIN |
| PCT/IB2011/002469 WO2012017327A2 (en) | 2010-08-06 | 2011-07-15 | Pharmaceutical composition and methods of treating and preventing the diseases caused by hiv or associated with hiv |
| EA201300134A EA032021B1 (en) | 2010-08-06 | 2011-07-15 | Pharmaceutical composition and method of treating and preventing the diseases caused by hiv and/or associated with hiv |
| UAA201300102A UA113389C2 (en) | 2010-08-06 | 2011-07-15 | Pharmaceutical composition and methods of treating and preventing the diseases caused by hiv or associated with hiv |
| US13/135,894 US20120263725A1 (en) | 2010-08-06 | 2011-07-15 | Pharmaceutical composition and methods of treating and preventing the diseases caused by HIV or associated with HIV |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2010133049/15A RU2010133049A (en) | 2010-08-06 | 2010-08-06 | MEDICINAL PRODUCT AND METHOD FOR PREVENTION OF HIV INFECTION, PREVENTION AND TREATMENT OF DISEASES CAUSED BY HIV OR ASSOCIATED WITH HIV, INCLUDING AIDS |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2010133049A true RU2010133049A (en) | 2012-02-20 |
Family
ID=44906251
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2010133049/15A RU2010133049A (en) | 2010-08-06 | 2010-08-06 | MEDICINAL PRODUCT AND METHOD FOR PREVENTION OF HIV INFECTION, PREVENTION AND TREATMENT OF DISEASES CAUSED BY HIV OR ASSOCIATED WITH HIV, INCLUDING AIDS |
Country Status (5)
| Country | Link |
|---|---|
| EA (1) | EA032021B1 (en) |
| FR (1) | FR2963562A1 (en) |
| RU (1) | RU2010133049A (en) |
| UA (1) | UA113389C2 (en) |
| WO (1) | WO2012017327A2 (en) |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4311897A (en) | 1979-08-28 | 1982-01-19 | Union Carbide Corporation | Plasma arc torch and nozzle assembly |
| RU2181297C2 (en) * | 2000-06-20 | 2002-04-20 | Эпштейн Олег Ильич | Method of treatment of pathological syndrome and medicinal agent |
| RU2192888C1 (en) | 2001-02-15 | 2002-11-20 | Эпштейн Олег Ильич | Medicinal agent and method of treatment of pathological syndrome |
| RU2001134982A (en) * | 2001-12-26 | 2004-02-20 | Олег Ильич Эпштейн | METHOD OF IMMUNE RESPONSE CORRECTION AND MEDICINE |
| UA76641C2 (en) | 2002-08-02 | 2006-08-15 | Олєг Ільіч Епштєйн | Homeopathic medicinal agent and method for curing diseases of prostate |
| UA76638C2 (en) | 2002-08-02 | 2006-08-15 | Oleh Illich Epshtein | Homeopathic medication based on anti-interferon antibodies and method for treating a pathological syndrome associated with interferon |
| WO2004082597A2 (en) | 2003-03-14 | 2004-09-30 | Nutrition Research, Inc. | Homeopathic formulations useful for treating pain and/or inflammmation |
-
2010
- 2010-08-06 RU RU2010133049/15A patent/RU2010133049A/en unknown
-
2011
- 2011-07-15 FR FR1156471A patent/FR2963562A1/en not_active Withdrawn
- 2011-07-15 EA EA201300134A patent/EA032021B1/en not_active IP Right Cessation
- 2011-07-15 WO PCT/IB2011/002469 patent/WO2012017327A2/en not_active Ceased
- 2011-07-15 UA UAA201300102A patent/UA113389C2/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2012017327A2 (en) | 2012-02-09 |
| WO2012017327A3 (en) | 2012-04-12 |
| EA201300134A1 (en) | 2014-03-31 |
| FR2963562A1 (en) | 2012-02-10 |
| UA113389C2 (en) | 2017-01-25 |
| EA032021B1 (en) | 2019-03-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2010133048A (en) | MEDICINAL PRODUCT AND METHOD FOR PREVENTION OF HIV INFECTION, PREVENTION AND TREATMENT OF DISEASES CAUSED BY HIV OR ASSOCIATED WITH HIV, INCLUDING AIDS | |
| RU2010133045A (en) | MEDICINAL PRODUCT AND METHOD FOR PREVENTION OF HIV INFECTION, PREVENTION AND TREATMENT OF DISEASES CAUSED BY HIV OR ASSOCIATED WITH HIV, INCLUDING AIDS | |
| JP2013538195A5 (en) | ||
| RU2011127226A (en) | METHOD FOR TREATING INFECTIOUS DISEASES AND AN INTEGRATED MEDICINE FOR THE TREATMENT OF INFECTIOUS DISEASES | |
| RU2010133046A (en) | METHOD AND MEANS FOR INHIBITING PRODUCTS OR STRENGTHEN ELIMINATION OF PROTEIN P24 | |
| RU2010133047A (en) | INTEGRATED MEDICINE AND METHOD FOR PREVENTION OF HIV INFECTION, PREVENTION AND TREATMENT OF DISEASES CAUSED BY HIV OR ASSOCIATED WITH HIV, INCLUDING AIDS | |
| RU2010133051A (en) | COMPREHENSIVE MEDICINE FOR TREATMENT OF INFLUENZA TREATMENT OF VARIOUS TYPES | |
| RU2013154072A (en) | MEDICINE FOR TREATMENT OF KINETOSIS AND METHOD OF TREATMENT OF KINETOSIS | |
| RU2010133053A (en) | INTEGRATED MEDICINE FOR TREATMENT OF VIRAL DISEASES AND METHOD OF TREATMENT OF VIRAL DISEASES | |
| RU2013154071A (en) | MEDICINAL PRODUCT AND METHOD FOR TREATMENT OF HEAD-WAYS | |
| RU2011127055A (en) | MEDICINAL PRODUCT FOR TREATMENT OF NEUROLOGICAL-BEHAVIORAL DEVELOPMENT DISORDERS AND METHOD OF TREATMENT OF NEUROLOGICAL-BEHAVIORAL DISORDERS OF DEVELOPMENT | |
| RU2010130358A (en) | MEDICINE FOR TREATMENT OF ATTENTION DEFICIENCY SYNDROME AND METHOD FOR TREATMENT OF ATTENTION DEFICIENCY SYNDROME | |
| RU2010133049A (en) | MEDICINAL PRODUCT AND METHOD FOR PREVENTION OF HIV INFECTION, PREVENTION AND TREATMENT OF DISEASES CAUSED BY HIV OR ASSOCIATED WITH HIV, INCLUDING AIDS | |
| RU2011127059A (en) | NEUROTROPIC MEDICINE AND METHOD OF TREATMENT OF ORGANIC DISEASES OF THE NERVOUS SYSTEM, PSYCHOORGANIC SYNDROME AND ENCEPHALOPATHY OF VARIOUS GENESIS | |
| RU2011127052A (en) | METHOD FOR TREATING THE HEAD-VARIABLE OF VARIOUS GENESIS, KINETOSIS AND VEGETOVASCULAR DYSTONIA (OPTIONS) AND MEDICINAL PRODUCT | |
| RU2010133052A (en) | INTEGRATED MEDICINE FOR TREATMENT OF VIRAL INFECTIONS AND METHOD OF TREATMENT OF VIRAL INFECTIONS | |
| RU2010133050A (en) | INTEGRATED MEDICINE FOR TREATMENT OF BACTERIAL INFECTIONS AND METHOD OF TREATMENT OF BACTERIAL INFECTIONS | |
| RU2011127058A (en) | MEDICINE FOR TREATMENT OF ALZHEIMER'S DISEASE AND METHOD OF TREATMENT OF ALZHEIMER'S DISEASE | |
| RU2013152871A (en) | DIABETES TREATMENT METHOD AND COMBINED MEDICINE | |
| RU2010133041A (en) | INTEGRATED MEDICINE AND METHOD FOR PREVENTION OF HIV INFECTION, PREVENTION AND TREATMENT OF DISEASES CAUSED BY HIV OR ASSOCIATED WITH HIV, INCLUDING AIDS | |
| RU2010130350A (en) | METHOD FOR TREATING DEPENDENCE ON PSYCHOACTIVE SUBSTANCES, ALCOHOLISM AND TOBACCO SMOKING AND MEDICINAL PRODUCT FOR TREATING DEPENDENCE ON PSYCHOACTIVE SUBSTANCES, ALCOHOLISM AND TOBACCO SMOKING | |
| RU2010131386A (en) | MEDICINAL PRODUCT FOR TREATMENT OF INFECTIOUS DISEASES ASSOCIATED WITH NEUROTOXIC DISORDERS, AND METHOD FOR TREATMENT OF INFECTIOUS DISEASES ASSOCIATED WITH NEUROTOXIC DISEASES | |
| RU2010133043A (en) | INTEGRATED MEDICINE AND METHOD FOR PREVENTION AND TREATMENT OF INFECTIOUS VIRAL DISEASES | |
| RU2013135854A (en) | PHARMACEUTICAL COMPOSITION | |
| RU2010130355A (en) | MEDICINAL PRODUCT AND METHOD FOR TREATMENT OF ORGANIC DISEASES OF THE NERVOUS SYSTEM, PSYCHOORGANIC SYNDROME AND ENCEPHALOPATHY OF VARIOUS GENESIS |